Clinical Trials Logo

Aortic Valve Stenosis clinical trials

View clinical trials related to Aortic Valve Stenosis.

Filter by:

NCT ID: NCT01487330 Completed - Clinical trials for Symptomatic Aortic Stenosis

First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System

SJM TAVI FIH
Start date: August 2011
Phase: N/A
Study type: Interventional

The purpose of this first-in-human study is to assess the technical feasibility, deployment characteristics, and safety of the 23mm SJM Transfemoral Transcatheter Heart Valve and delivery system in subjects with severe symptomatic aortic stenosis (AS). This is a single center, prospective, non-randomized, first-in-human investigational study without concurrent or matched controls.

NCT ID: NCT01448421 Completed - Aortic Stenosis Clinical Trials

DEFLECT I: Keystone Heart Embolic Deflection Trial

Start date: March 2012
Phase: N/A
Study type: Interventional

This is a research study using the Keystone Heart Embolic Deflection Device and involving patients with aortic stenosis (a disease of the aortic valve), to be treated with Transcatheter Aortic Valve Replacement (TAVR). The TAVR procedure consists in replacing the diseased aortic valve by a new artificial valve. The new valve is put into place using a long, thin tube called a catheter that is inserted into a small incision (cut) in the patient's groin and threaded through his/her arteries up to the heart.

NCT ID: NCT01445171 Completed - Clinical trials for Aortic Valve Stenosis

Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve

TRITON
Start date: January 2010
Phase: N/A
Study type: Interventional

The purpose of this clinical investigation is to confirm that the safety and performance of the EDWARDS INTUITY Valve System.

NCT ID: NCT01437098 Completed - Clinical trials for Aortic Valve Stenosis

Clinical Evaluation of MDT-2111 in Subjects With Symptomatic Severe Aortic Stenosis

Start date: October 2011
Phase: N/A
Study type: Interventional

The primary objective of the present trial is to demonstrate the effectiveness and safety of the MDT-2111 in the treatment of symptomatic severe aortic stenosis in subjects deemed difficult for surgical operation.

NCT ID: NCT01422044 Completed - Aortic Stenosis Clinical Trials

Risk Prediction in Aortic Stenosis

PREDICT-AS
Start date: September 2009
Phase: N/A
Study type: Observational

The purpose of this study is to test the prognostic value of autonomic markers in patients with aortic stenosis.

NCT ID: NCT01419015 Completed - Clinical trials for Aortic Valve Stenosis

PREVAIL-20J - Transfemoral Placement of 20mm Aortic Balloon Expandable Transcatheter Valve Trial

PREVAIL-20J
Start date: June 2011
Phase: N/A
Study type: Interventional

A single arm, prospective multicenter non-randomized pivotal clinical trial evaluating the 20mm Edwards SAPIEN XT™ transcatheter heart valve (model 9300TFX), NovaFlex™ transfemoral delivery system, and crimper accessories. The trial includes a premarket pivotal cohort to evaluate the system performance as well as a post market clinical follow-up phase involving long term follow-up of all patients to evaluate the safety of investigational devices up to 5 years.

NCT ID: NCT01404975 Completed - Aortic Stenosis Clinical Trials

TAVI Protocol - Paravertebral Block Study

TAVI PVB
Start date: June 2011
Phase: N/A
Study type: Interventional

Trans-apical aortic valve replacement is a new treatment for severe aortic stenosis. It is offered to elderly patients with medical problems that would markedly increase the risk of conventional cardiac surgery. The rate of delirium (acute confusional state) after surgery in these patients may exceed 50%. Estimated hospital costs associated with delirium at Toronto General Hospital last year exceeded $1-million CAD. Pain after surgery and the use of opioids (morphine type of pain-relief drugs) are known to increase the risk of delirium. The investigators plan to minimize the use of opioids and improve pain management by replacing the standard intravenous opioid-based pain management with the paravertebral nerve block using only the local anesthetic. These two management strategies will be compared with respect to the rate of delirium, duration of hospital stay, and the overall costs. Hypothesis: Paravertebral analgesia with LA decreases the incidence of delirium after trans-apical AVR when compared to standard systemic opioid-based analgesia.

NCT ID: NCT01395303 Completed - Stroke Clinical Trials

Polymorphisms in the Vitamin D System and Health

Start date: April 2011
Phase: N/A
Study type: Observational

Polymorphisms in the vitamin D system appear to affect the serum 25(OH)D levels. If so one would expect these polymorphisms to be associated with vitamin D related conditions and diseases, which will be tested in the present study including DNA analyses in 9700 subjects

NCT ID: NCT01390129 Completed - Clinical trials for Aortic Valve Stenosis

Remote Ischemic Preconditioning in Aortic Valve Surgery

RIP-Valve
Start date: July 2011
Phase: N/A
Study type: Interventional

RIP-VALVE is a randomized, single blinded study that will test the hypothesis that remote ischemic preconditioning initiated before surgery reduces post-operative myocardial damage in aortic valve surgery. Infarct size will be determined by 72 hours area under curve of troponin-I.

NCT ID: NCT01358513 Completed - Aortic Stenosis Clinical Trials

Role of Active Valvular Calcification and Inflammation in Patients With Aortic Stenosis

Start date: July 2010
Phase:
Study type: Observational

The aortic valve is the main outlet valve from the heart. This valve can become diseased and narrowed when it needs to be replaced with an artificial valve. Currently, this is the commonest reason for someone to undergo a heart valve operation in the UK. Unfortunately, there are no medical treatments that can prevent or delay the progression of this disease process. Here, the investigators propose to use new state-of-the-art imaging techniques to better understand the disease process so that the investigators can effectively design and assess potential new treatments. The ultimate aim is to stop this disease before patients need to have surgery. In addition the investigators believe this technique will allow us to predict the rate of progression of the disease